Sign in

CIK 0001425205

  • Accelerated filer

IOVANCE BIOTHERAPEUTICS, INC.

Sign in to watch
Ticker
IOVA
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
753254381
Phone
+1 650-260-7120
Business address
825 INDUSTRIAL ROAD, 4TH FLOOR, SAN CARLOS, CA, 94070
Former names
Lion Biotechnologies, Inc., Genesis Biopharma, Inc, FREIGHT MANAGEMENT CORP
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$0
in 0 filings

Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 99 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2026-06-16 Dukes Iain D. Director Grant or award · Deferred Restricted Stock Unit +180,632 180,632
2025-06-13 Dukes Iain D. Director Grant or award · Deferred Restricted Stock Unit +135,092 135,092
2024-06-11 Dukes Iain D. Director Grant or award · Deferred Restricted Stock Unit +98,607 98,607
2024-03-01 Dukes Iain D. Director Grant or award · Deferred Restricted Stock Unit +100,000 100,000
2024-02-20 Dukes Iain D. Director Purchase +32,000 $9.15 $293K 54,000
2023-06-06 Dukes Iain D. Director Grant or award · Deferred Restricted Stock Unit +103,911 103,911
2022-11-23 Dukes Iain D. Director Purchase +10,000 $6.10 $61K 22,000
2022-06-10 Dukes Iain D. Director Grant or award · Deferred Restricted Stock Unit +102,409 102,409
2021-06-29 Dukes Iain D. Director Grant or award · Stock Option (right to buy) +70,000 70,000
2020-06-08 Dukes Iain D. Director Grant or award · Stock Option (right to buy) +70,000 70,000

Page 1 of 1 · 10 trades